The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 14, 2022

Filed:

Nov. 09, 2016
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Shinji Hatakeyama, Basel, CH;

Ronenn Roubenoff, Brookline, MA (US);

Estelle Trifilieff, Dietwiller, FR;

Jerome Feige, Village Neuf, FR;

Lloyd B. Klickstein, Newton, MA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61P 21/00 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 31/436 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/436 (2013.01); A61K 33/243 (2019.01); A61P 21/00 (2018.01); A61P 35/00 (2018.01);
Abstract

The present invention relates to myostatin antagonists, for the treatment of cancer cachexia, and cancer cachexia due to chemotherapeutic treatment. In particular, the myostatin antagonist bimagrumab was found to be beneficial in the treatment of cancer cachexia by reducing body weight loss. The present invention also relates to combinations and uses of a myostatin antagonist and an mTOR inhibitor for treating cancer cachexia by reducing, maintaining or increasing body weight loss or for use in treating age-related conditions.


Find Patent Forward Citations

Loading…